Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01514981 · ClinicalTrials.gov registry record · Phase 1
AMG 761 in Adults With Asthma
A Phase 1 study, sponsored by Amgen.
- Terminated
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT01514981 is a Phase 1 study that was terminated before completion, run by Amgen. The registered enrollment target is 7 participants.
The verdict
NCT01514981, a Phase 1 study, was terminated before completion, sponsored by Amgen.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to determine that no significant safety issues will be identified following a single dose of AMG 761 in asthma subjects that would preclude further development of AMG 761.
Interventions
- DRUG Placebo
- DRUG AMG 761
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01514981
The ClinicalTrials.gov registry entry for NCT01514981 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01514981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01514981 about?
NCT01514981 is a clinical study titled "AMG 761 in Adults With Asthma". The purpose of this study is to determine that no significant safety issues will be identified following a single dose of AMG 761 in asthma subjects that would preclude further development of AMG 761.
What is the current status of trial NCT01514981?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2011-12. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01514981?
The interventions under investigation include: Placebo (DRUG), AMG 761 (DRUG).
Who is sponsoring clinical trial NCT01514981?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.